✦ LIBER ✦

Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes

✍ Scribed by Jin, Huajun; Kanthasamy, Arthi; Ghosh, Anamitra; Anantharam, Vellareddy; Kalyanaraman, Balaraman; Kanthasamy, Anumantha G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitochondria-Targeted Antioxidants in th

✍ Robin A.J. Smith; Victoria J. Adlam; Frances H. Blaikie; Abdul-Rahman B. Manas; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Thiazolidinediones under preclinical and

✍ Carta, Anna R; Simuni, Tanya 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 262 KB

Mitochondria and Antioxidant Targeted Th

✍ Dumont, Magali ;Lin, Michael T. ;Beal, M. Flint ;Zhu, Xiongwei (editor);Beal, M. 📂 Article 📅 2010 🏛 IOS Press 🌐 English ⚖ 83 KB

Experimental modeling of preclinical and

✍ V. G. Khaindrava; E. A. Kozina; V. S. Kudrin; V. G. Kucheryanu; P. D. Klodt; V. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 368 KB

Clinical outcomes for stages of NIA-AA p

✍ David Knopman; Clifford Jack; Heather Wiste; Stephen Weigand; Prashanthi Vemuri; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

The relevance of preclinical studies for

✍ Gerlach, M.; Foley, P.; Riederer, P. 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 169 KB